NIH-funded clinical trial will determine safety, tolerability of experimental drug Business Announcement NIH/NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES WHAT:A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun. The trial is testing the safety, tolerability and processing in the body of escalating doses of the...
